UK markets closed

Novartis AG (0QLR.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
82.56-0.29 (-0.35%)
At close: 06:45PM BST
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 323.65%
S&P500 52-week change 321.08%
52-week high 393.98
52-week low 373.79
50-day moving average 390.34
200-day moving average 386.60

Share statistics

Avg vol (3-month) 3603.13k
Avg vol (10-day) 31.12M
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.95B
% held by insiders 14.12%
% held by institutions 139.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 33.92
Trailing annual dividend yield 34.73%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 31.94%
Operating margin (ttm)30.78%

Management effectiveness

Return on assets (ttm)8.65%
Return on equity (ttm)19.83%

Income statement

Revenue (ttm)47.73B
Revenue per share (ttm)23.17
Quarterly revenue growth (yoy)9.70%
Gross profit (ttm)N/A
EBITDA 18.94B
Net income avi to common (ttm)9.11B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)17.20%

Balance sheet

Total cash (mrq)9.65B
Total cash per share (mrq)4.73
Total debt (mrq)27.28B
Total debt/equity (mrq)68.63%
Current ratio (mrq)0.90
Book value per share (mrq)19.44

Cash flow statement

Operating cash flow (ttm)13.77B
Levered free cash flow (ttm)13.33B